Last reviewed · How we verify
Fospropofol disodium for injection
Fospropofol disodium is a prodrug that is converted to propofol, a GABA_A receptor agonist, leading to sedation and hypnosis.
Fospropofol disodium is a prodrug that is converted to propofol, a GABA_A receptor agonist, leading to sedation and hypnosis. Used for Sedation for diagnostic or surgical procedures.
At a glance
| Generic name | Fospropofol disodium for injection |
|---|---|
| Also known as | Remifentanil, sulfentanyl |
| Sponsor | Xiaobo Yang, MD |
| Drug class | GABA_A receptor agonist |
| Target | GABA_A receptor |
| Modality | Small molecule |
| Therapeutic area | Anesthesiology |
| Phase | Phase 2 |
Mechanism of action
Fospropofol disodium is a water-soluble prodrug that is metabolized to propofol, which then acts as a potent agonist of the GABA_A receptor. This results in the enhancement of inhibitory neurotransmission in the brain, leading to sedative and hypnotic effects.
Approved indications
- Sedation for diagnostic or surgical procedures
Common side effects
- Respiratory depression
- Hypotension
- Nausea and vomiting
Key clinical trials
- Clinical Study of Fospropofol Disodium for Injection in the Painless Endoscopic Diagnosis and Treatment (NA)
- Efficacy and Safety of Fospropofol Disodium Versus Propofol for Sedation in Mechanically Ventilated ICU Patients (PHASE2)
- Efficacy and Safety of Fospropofol Disodium Versus Propofol for Deep Sedation in Critically Ill Patients (PHASE2)
- A Study of AQUAVAN® Injection Versus Midazolam HCl for Sedation in Elderly Patients Undergoing Elective Colonoscopy (PHASE2)
- A Study of AQUAVAN® Injection for Sedation in Elderly Patients Undergoing Flexible Bronchoscopy (PHASE3)
- A Study to Characterize Pharmacokinetics (PK) and Pharmacodynamics (PD) of LUSEDRA® Administered as Continuous Infusion or Bolus Compared With Continuous Infusion of Propofol Injectable Emulsion (PHASE1)
- A Study of AQUAVAN® Injection in the Presence of Pre-Medication in Patients Undergoing Minor Surgical Procedures (PHASE3)
- Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |